Ashoka is the largest global network of social entrepreneurs with system-changing solutions, focussing on creating an “Everyone is a changemaker” world. Ashoka has had a presence in Africa since 1990 and elected over 500 Ashoka Fellows in 20 countries who have been innovating alongside youth and changemakers from the corporate, investment, media and policy spaces. Ashoka is spotting patterns and trends in social innovation and facilitate the emergence of collaborative models that can address the most critical societal challenges at scale.
The British Council was founded in 1934 to create friendly knowledge and understanding between the people of the UK and the wider world. Across Africa, the British Council creates opportunity, especially for young people to fulfil their potential by improving their employability, resilience and networks. Part of this is delivered through the British Council’s Global Social Enterprise programme which enables social enterprise as a route to positive social change, inclusive growth and sustainable development while also sharing learning and building trust between the UK and other countries.
RESPONSIBLE BUSINESS FORUM
CTA is a joint international institution of the African, Caribbean and Pacific (ACP) Group of States and the European Union (EU). CTA operates under the framework of the Cotonou Agreement and is funded by the EU. CTA’s activities contribute directly toward achieving the UN’s Sustainable Development Goals (SDGs) with specific focus on:
GOAL 1 – No poverty:
End poverty in all its forms everywhere.
GOAL 2 – Zero hunger:
End hunger, achieve food security and improved nutrition and promote sustainable agriculture.
GOAL 5 – Gender equality:
Achieve gender equality and empower all women and girls.
GOAL 8 – Decent work and economic growth:
Promote inclusive and sustainable economic growth, employment and decent work for all.
GOAL 13 – Climate action:
Take urgent action to combat climate change and its impacts.
CTA’s headquarters are located in Wageningen, the Netherlands. An additional branch is located in Brussels, Belgium. CTA is primarily funded by the European Development Fund but receives additionally funding through a diverse set of international partners. CTA is active in 79 ACP countries.
Improving the health and quality of life of patients is the goal of the research-driven pharmaceutical company Boehringer Ingelheim. The focus in doing so is on diseases for which no satisfactory treatment option exists to date. The company therefore concentrates on developing innovative therapies that can extend patients’ lives. In animal health, Boehringer Ingelheim stands for advanced prevention. Family-owned since it was established in 1885, Boehringer Ingelheim is one of the pharmaceutical industry’s top 20 companies. Some 50,000 employees create value through innovation daily for the three business areas human pharmaceuticals, animal health and biopharmaceuticals. In 2017, Boehringer Ingelheim achieved net sales of around 18.1 billion euros. R&D expenditure, exceeding three billion euros, corresponded to 17.0 per cent of net sales. As a family-owned company, Boehringer Ingelheim plans in generations and focuses on long-term success, rather than short-term profit. The company therefore aims at organic growth from its own resources with simultaneous openness to partnerships and strategic alliances in research. In everything it does, Boehringer Ingelheim naturally adopts responsibility towards mankind and the environment.
SWISS AGENCY FOR DEVELOPMENT AND COOPERATION
FREY CHARITABLE FOUNDATION